| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLCM | BELLICUM PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Nov 22, 2023 | Option Exercise | $0.00010 | 2,116,349 | 212 | 2,168,818 | Nov 24, 2023, 01:39 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Ward Shane | Sr VP and Chief Legal SO | May 29, 2020 | Option Exercise | $7.63 | 107 | 816 | 1,879 | Jun 02, 2020, 12:25 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Fair Richard A. | President and CEO | Mar 17, 2020 | Buy | $4.00 | 5,000 | 19,999 | 5,000 | Mar 19, 2020, 12:48 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Williams Rosemary Y. | VP, Finance & PAO | Jan 02, 2020 | Option Exercise | $1.51 | 483 | 729 | 5,270 | Jan 06, 2020, 05:15 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Williams Rosemary Y. | VP, Finance & PAO | Jan 03, 2020 | Option Exercise | $1.40 | 295 | 413 | 5,756 | Jan 06, 2020, 05:15 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jan 02, 2020 | Option Exercise | $1.51 | 883 | 1,333 | 5,982 | Jan 06, 2020, 05:00 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jan 03, 2020 | Option Exercise | $1.40 | 589 | 825 | 6,956 | Jan 06, 2020, 05:00 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Foster Aaron E. | Sr VP, Head of Research | Jan 03, 2020 | Option Exercise | $1.40 | 236 | 330 | 7,281 | Jan 06, 2020, 04:29 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Foster Aaron E. | Sr VP, Head of Research | Jan 02, 2020 | Option Exercise | $1.51 | 942 | 1,422 | 6,892 | Jan 06, 2020, 04:29 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Woodard Jr Joseph Paul | SVP Clinical & Medical Affairs | Nov 13, 2019 | Option Exercise | $0.82 | 1,597 | 1,310 | 5,467 | Nov 14, 2019, 05:11 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Fair Richard A. | President and CEO | Sep 10, 2019 | Buy | $1.25 | 40,000 | 50,000 | 66,561 | Sep 11, 2019, 07:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Ward Shane | Sr. VP and General Counsel | Aug 29, 2019 | Buy | $1.23 | 8,000 | 9,822 | 18,294 | Aug 30, 2019, 04:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Naeve Gregory S. | Chief Business Officer | Aug 21, 2019 | Option Exercise | $0.95 | 1,597 | 1,513 | 13,746 | Aug 23, 2019, 04:04 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Fair Richard A. | President and CEO | Aug 21, 2019 | Buy | $0.99 | 20,000 | 19,780 | 26,561 | Aug 23, 2019, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Ward Shane | Sr. VP and General Counsel | May 29, 2019 | Option Exercise | $2.09 | 1,065 | 2,226 | 8,935 | May 30, 2019, 04:05 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Grossman William | Sr. VP, Chief Medical Officer | Feb 05, 2019 | Option Exercise | $3.48 | 3,126 | 10,878 | 26,874 | Feb 07, 2019, 04:02 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Naeve Gregory S. | Chief Business Officer | Jan 02, 2019 | Option Exercise | $3.33 | 993 | 3,307 | 14,441 | Jan 04, 2019, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Williams Rosemary Y. | Principal Accounting Officer | Jan 03, 2019 | Option Exercise | $3.20 | 295 | 944 | 4,471 | Jan 04, 2019, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Williams Rosemary Y. | Principal Accounting Officer | Jan 02, 2019 | Option Exercise | $3.33 | 483 | 1,608 | 3,984 | Jan 04, 2019, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jan 02, 2019 | Option Exercise | $3.33 | 883 | 2,940 | 3,548 | Jan 04, 2019, 04:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jan 03, 2019 | Option Exercise | $3.20 | 589 | 1,885 | 4,521 | Jan 04, 2019, 04:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Technology Officer | Jan 02, 2019 | Option Exercise | $3.33 | 942 | 3,137 | 91,497 | Jan 04, 2019, 12:00 AM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Technology Officer | Jan 03, 2019 | Option Exercise | $3.20 | 589 | 1,885 | 92,470 | Jan 04, 2019, 12:00 AM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Stonehouse Jon P | Director | Nov 09, 2018 | Buy | $4.56 | 10,000 | 45,600 | 10,000 | Nov 13, 2018, 04:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Technology Officer | Sep 04, 2018 | Sale | $7.04 | 10,000 | 70,413 | 89,939 | Sep 05, 2018, 04:02 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Naeve Gregory S. | Chief Business Officer | Aug 21, 2018 | Option Exercise | $6.74 | 1,597 | 10,764 | 13,403 | Aug 23, 2018, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Technology Officer | Jul 18, 2018 | Sale | $7.63 | 40,000 | 305,132 | 99,939 | Jul 20, 2018, 04:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | May 25, 2018 | Sale | $7.97 | 6,206 | 49,466 | 26,548 | May 29, 2018, 04:49 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | BAKER BROS. ADVISORS LP | 10% Owner | Jan 18, 2018 | Sale | $8.12 | 324,774 | 2,635,768 | 4,000,484 | Jan 19, 2018, 04:57 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | BAKER JULIAN | 10% Owner | Jan 19, 2018 | Sale | $7.91 | 295,361 | 2,336,217 | 3,734,776 | Jan 19, 2018, 04:57 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 17, 2018 | Sale | $8.63 | 260,600 | 2,247,910 | 4,292,652 | Jan 19, 2018, 04:57 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jan 09, 2018 | Sale | $9.40 | 487 | 4,578 | 2,087 | Jan 11, 2018, 04:02 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | Jan 03, 2018 | Option Exercise | $9.79 | 706 | 6,912 | 32,754 | Jan 05, 2018, 04:04 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Jan 03, 2018 | Option Exercise | $9.79 | 589 | 5,766 | 139,939 | Jan 05, 2018, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jan 03, 2018 | Option Exercise | $9.79 | 589 | 5,766 | 2,574 | Jan 05, 2018, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Jan 03, 2018 | Option Exercise | $9.79 | 589 | 5,766 | 1,465 | Jan 05, 2018, 04:03 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | Dec 11, 2017 | Sale | $9.33 | 17,117 | 159,667 | 31,585 | Dec 13, 2017, 04:05 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | Nov 27, 2017 | Sale | $9.89 | 6,206 | 61,382 | 48,702 | Nov 29, 2017, 05:06 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Smith Alan K. | EVP, Technical Operations | Jul 24, 2017 | Sale | $11.85 | 437 | 5,178 | 1,600 | Jul 26, 2017, 04:29 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Jul 13, 2017 | Sale | $7.41 | 27,646 | 204,719 | 14,314 | Jul 17, 2017, 04:20 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Jul 10, 2017 | Sale | $11.54 | 10,000 | 115,400 | 138,965 | Jul 12, 2017, 04:43 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | May 25, 2017 | Sale | $12.24 | 6,311 | 77,254 | 54,908 | May 26, 2017, 03:07 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | BAKER JULIAN | 10% Owner | Mar 24, 2017 | Buy | $12.00 | 166,666 | 1,999,992 | 4,527,089 | Mar 28, 2017, 05:05 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Director | Feb 07, 2017 | Sale | $12.54 | 30,000 | 376,215 | 294,982 | Feb 09, 2017, 04:11 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Dec 15, 2016 | Sale | $15.45 | 30,000 | 463,539 | 324,982 | Dec 19, 2016, 04:13 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Dec 05, 2016 | Sale | $20.00 | 5,000 | 100,000 | 146,082 | Dec 05, 2016, 06:42 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Dec 01, 2016 | Sale | $17.52 | 5,000 | 87,624 | 153,115 | Dec 05, 2016, 04:09 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Annemarie | COO/EVP Clinical Development | Dec 01, 2016 | Sale | $10.05 | 50,000 | 502,255 | 25,442 | Dec 05, 2016, 04:07 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | Nov 25, 2016 | Sale | $20.48 | 6,273 | 128,480 | 83,575 | Nov 29, 2016, 04:05 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | Nov 28, 2016 | Sale | $19.25 | 23,027 | 443,160 | 61,148 | Nov 29, 2016, 04:05 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 23, 2016 | Sale | $20.19 | 6,200 | 125,172 | 156,082 | Sep 23, 2016, 06:57 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 21, 2016 | Sale | $20.04 | 300 | 6,012 | 172,282 | Sep 23, 2016, 06:57 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 22, 2016 | Sale | $19.68 | 10,000 | 196,832 | 162,282 | Sep 23, 2016, 06:57 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 21, 2016 | Sale | $20.04 | 100 | 2,004 | 366,940 | Sep 23, 2016, 06:56 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 23, 2016 | Sale | $20.12 | 11,258 | 226,549 | 84,206 | Sep 23, 2016, 06:56 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 23, 2016 | Sale | $20.11 | 11,958 | 240,530 | 354,982 | Sep 23, 2016, 06:56 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 21, 2016 | Sale | $20.04 | 100 | 2,004 | 95,464 | Sep 23, 2016, 06:56 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Sep 21, 2016 | Option Exercise | $13.76 | 200 | 2,751 | 444 | Sep 23, 2016, 06:55 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Sep 23, 2016 | Option Exercise | $13.79 | 23,400 | 322,597 | 12,044 | Sep 23, 2016, 06:55 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 20, 2016 | Sale | $20.00 | 300 | 6,000 | 95,564 | Sep 20, 2016, 06:21 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 20, 2016 | Sale | $20.00 | 100 | 2,000 | 367,040 | Sep 20, 2016, 06:21 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 16, 2016 | Sale | $20.00 | 942 | 18,840 | 97,264 | Sep 20, 2016, 06:21 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 16, 2016 | Sale | $20.00 | 636 | 12,720 | 368,346 | Sep 20, 2016, 06:21 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 19, 2016 | Sale | $20.02 | 1,400 | 28,024 | 95,864 | Sep 20, 2016, 06:21 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Sep 19, 2016 | Sale | $20.01 | 1,206 | 24,129 | 367,140 | Sep 20, 2016, 06:21 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 16, 2016 | Sale | $20.01 | 1,700 | 34,015 | 173,382 | Sep 20, 2016, 06:20 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 19, 2016 | Sale | $20.02 | 700 | 14,013 | 172,682 | Sep 20, 2016, 06:20 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 20, 2016 | Sale | $20.00 | 100 | 2,000 | 172,582 | Sep 20, 2016, 06:20 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Sep 20, 2016 | Option Exercise | $13.73 | 400 | 5,494 | 544 | Sep 20, 2016, 06:19 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Sep 16, 2016 | Sale | $13.73 | 1,400 | 19,229 | 1,044 | Sep 20, 2016, 06:19 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Sep 19, 2016 | Option Exercise | $13.74 | 2,600 | 35,729 | 1,644 | Sep 20, 2016, 06:19 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Aug 15, 2016 | Sale | $19.32 | 31,000 | 598,931 | 370,982 | Aug 17, 2016, 04:11 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Aug 15, 2016 | Sale | $19.31 | 36,000 | 695,012 | 100,079 | Aug 17, 2016, 04:11 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Aug 15, 2016 | Sale | $20.00 | 1,000 | 20,000 | 175,082 | Aug 17, 2016, 04:09 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Aug 15, 2016 | Option Exercise | $13.73 | 2,000 | 27,470 | 1,344 | Aug 17, 2016, 04:09 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Jul 27, 2016 | Sale | $15.00 | 15,000 | 225,000 | 399,982 | Jul 29, 2016, 05:50 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Jul 27, 2016 | Sale | $15.00 | 10,000 | 150,000 | 176,082 | Jul 29, 2016, 05:48 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Jul 18, 2016 | Sale | $13.99 | 2,719 | 38,044 | 134,206 | Jul 19, 2016, 06:42 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Jul 15, 2016 | Sale | $13.72 | 22,281 | 305,677 | 136,925 | Jul 19, 2016, 04:02 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Annemarie | COO/EVP Clinical Development | Jun 02, 2016 | Sale | $7.77 | 50,000 | 388,750 | 18,486 | Jun 06, 2016, 04:06 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Jun 02, 2016 | Sale | $7.77 | 30,000 | 233,250 | 15,196 | Jun 06, 2016, 04:06 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Apr 22, 2016 | Sale | $11.43 | 30,000 | 342,788 | 415,182 | Apr 26, 2016, 04:06 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Apr 22, 2016 | Sale | $11.43 | 25,000 | 285,710 | 159,206 | Apr 26, 2016, 04:06 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Annemarie | COO/EVP Clinical Development | Jan 04, 2016 | Sale | $10.81 | 70,000 | 756,744 | 35,251 | Jan 06, 2016, 04:20 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Dec 14, 2015 | Option Exercise | $2.55 | 5,000 | 12,750 | 184,559 | Dec 16, 2015, 04:04 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Dec 01, 2015 | Sale | $22.95 | 5,000 | 114,739 | 178,600 | Dec 03, 2015, 04:16 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Musso Alan A | CFO and Treasurer | Nov 24, 2015 | Sale | $22.34 | 29,300 | 654,459 | 88,742 | Nov 27, 2015, 04:50 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Nov 16, 2015 | Sale | $20.65 | 4,000 | 82,585 | 398,066 | Nov 18, 2015, 11:44 AM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Nov 16, 2015 | Sale | $20.65 | 6,000 | 123,877 | 184,206 | Nov 18, 2015, 11:44 AM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Nov 16, 2015 | Sale | $20.65 | 14,000 | 289,047 | 444,981 | Nov 18, 2015, 11:44 AM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Moseley Ken | Sr. VP and General Counsel | Nov 02, 2015 | Option Exercise | $7.77 | 30,000 | 233,250 | 15,097 | Nov 04, 2015, 01:36 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Farrell Thomas J. | President and CEO | Oct 01, 2015 | Sale | $14.58 | 2,500 | 36,442 | 63,862 | Oct 06, 2015, 06:11 AM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 21, 2015 | Option Exercise | $2.55 | 5,000 | 12,750 | 183,600 | Sep 23, 2015, 05:14 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Sep 11, 2015 | Sale | $19.00 | 5,000 | 95,000 | 178,600 | Sep 15, 2015, 04:11 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Farrell Thomas J. | President and CEO | Sep 01, 2015 | Sale | $16.78 | 2,500 | 41,943 | 66,362 | Sep 03, 2015, 04:55 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Farrell Thomas J. | President and CEO | Aug 03, 2015 | Sale | $20.24 | 2,500 | 50,608 | 68,862 | Aug 05, 2015, 05:07 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Jul 15, 2015 | Sale | $20.00 | 3,500 | 70,000 | 458,981 | Jul 17, 2015, 04:59 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Jul 15, 2015 | Sale | $20.00 | 1,000 | 20,000 | 402,066 | Jul 17, 2015, 04:59 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Slawin Kevin M. | Chief Technology Officer | Jul 15, 2015 | Sale | $20.00 | 1,500 | 30,000 | 163,008 | Jul 17, 2015, 04:59 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Spencer David M. | Chief Scientific Officer | Jul 02, 2015 | Option Exercise | $2.55 | 20,000 | 51,000 | 183,600 | Jul 07, 2015, 04:59 PM |
Menu